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Abstract A decrease in interaction between brain regions
is observed in individuals with autism spectrum disorder
(ASD), which is believed to be related to restricted neural
network access in ASD. Propranolol, a beta-adrenergic
antagonist, has revealed benefit during performance of
tasks involving flexibility of access to networks, a benefit
also seen in ASD. Our goal was to determine the effect of
propranolol on functional connectivity in ASD during a
verbal decision making task as compared to nadolol,
thereby accounting for the potential spurious fMRI effects
due to peripheral hemodynamic effects of propranolol. Ten
ASD subjects underwent fMRI scans after administration of
placebo, propranolol or nadolol, while performing a
phonological decision making task. Comparison of func-
tional connectivity between pre-defined ROI-pairs revealed
a significant increase with propranolol compared to
nadolol, suggesting a potential imaging marker for the
cognitive effects of propranolol in ASD.
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Introduction
Autism is a neurodevelopmental disorder characterized by
impaired social interaction, impaired communication and
repetitive and restricted behaviors (Lord et al. 1994). While
varying degrees of mental retardation are common in
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cognitive impairment encounter significant problems trying
to function in society (Morgan 1996; Carpenter 1992).
Autism spectrum disorder (ASD) is a term used to
describe the spectrum of autism, Asperger syndrome
and pervasive developmental disorder—not otherwise
specified (Beversdorf et al. 1998).
Several theories have been proposed to explain the
impairments in autism, including inability to comprehend
the perspectives of others (“theory of mind”) (Baron-Cohen
et al. 1985), inability to process emotional information
(Hobson 1991, 1993; Fotheringham 1991) and impaired
executive function (Rumsey 1985; Rumsey and Hamburger
1988, 1990). Individuals with autism are also known to
have decreased central coherence, or difficulty with
utilization of context to process its environmental relevance
(Frith and Happé 1994; Happé 1994). This lack of central
coherence is believed be related to restriction of semantic
and associative networks, leading to the observed deficits in
semantic clustering in verbal memory (Minshew and
Goldstein 2001). This also relates to superior performance
in recognition on “false memory” tasks (Beversdorf et al.
2000), proposed to be associated with increased neuronal
density and decreased neuronal size in the hippocampus,
among other atypical findings in the brain in autism
(Bauman and Kemper 1985, 1994).
More recently, a potential neural correlate of this phenom-
enon of network underconnectivity and decreased context
utilization in autism has been revealed, with the demonstra-
tion of decreased functional connectivity, defined as the
‘temporal correlation between spatially remote neurophysio-
logical events’ (Friston 1994). This is demonstrated by
decreased functional connectivity fMRI (fcMRI) during
sentence comprehension and working memory in high
functioning individuals with autism (Just et al. 2004), and
during a range of other cognitive tasks (Koshino et al. 2005).
Our recent pilot evidence has suggested a benefit in
flexibility of access to networks on verbal problem solving
tasks with propranolol in ASD (Beversdorf et al. 2008). In
this study, subjects with ASD solved simple anagram tasks,
which involved a search through the lexical/semantic
network to find the solution (for example, ‘BRICK’ is the
solution to ‘IRBCK’), more quickly after administration of
propranolol than after placebo. Therefore, we wished to
determine whether propranolol might also result in an
increase in functional connectivity in ASD.
Propranolol, a β-adrenergic antagonist, appears to affect
flexibility of access to lexical, semantic and associative
networks on verbal problem solving tasks in individuals
without neurodevelopmental diagnoses (Beversdorf et al.
1999). In the initial work, anagram performance was better
after propranolol, a β-adrenergic antagonist, as compared to
ephedrine, an adrenergic agonist (Beversdorf et al. 1999).
In subsequent work, anagram performance was found to be
significantly better after propranolol, which blocks both
central and peripheral β-adrenergic receptors, as compared
to nadolol, which blocks only peripheral β-adrenergic
receptors, suggesting that noradrenergic modulation of
cognitive flexibility is mediated by a central, rather than a
peripheral mechanism (Beversdorf et al. 2002). However, in
neither of these initial small studies in individuals without
developmental diagnoses did the improvement with pro-
pranolol as compared to placebo reach significance. In
order to better understand the effect of propranolol, a
subsequent larger study was performed, which revealed a
significant benefit from propranolol for the subjects slowest
at solving the problems, as well as for the most difficult
problems regardless of subject (Campbell et al. 2008).
However, benefit was not observed for subjects best at
solving the problems, or for simple problems regardless of
subject, with a decline in performance occasionally ob-
served with propranolol in these cases. This was true for
anagrams as well as other verbal problem solving tasks
requiring flexibility of access to lexical, semantic and
associative networks. In contrast to the studies in individ-
uals without neurodevelopmental diagnoses, in the study
examining the effect of propranolol in ASD a benefit was
observed for the simplest anagrams with propranolol as
compared to placebo, despite a slight decline in perfor-
mance with the same tasks with propranolol among control
participants (Beversdorf et al. 2008).
The effect of propranolol is believed to be due to the
modulatory effect of norepinephrine on the signal-to-
noise ratio (SNR) of neuronal activity within the cortex
(Hasselmo et al. 1997). Increased SNR would be expected
to increase the relative strength of dominant responses, but
decreased SNR may allow greater access to more remote
associative inputs, which may benefit cognitive flexibility
in unconstrained tasks such as those involving search of
semantic and associative networks (Hasselmo et al. 1997;
Alexander et al. 2007). This is consistent with the
aforementioned finding where propranolol benefitted solv-
ing difficult verbal problem solving tasks, but not simple
tasks, in individuals without neurodevelopmental diagnoses
(Campbell et al. 2008). In addition, propranolol was shown
to reverse the cognitive impairment induced by stress
(Alexander et al. 2007) and acute cocaine withdrawal
(Kelley et al. 2007), during which the observed deleterious
effects on cognitive performance is believed to be due to
noradrenergic upregulation, regardless of task difficulty.
Both social and language benefits have been reported
with β-blockers in a pilot case series study in autism (Ratey
et al. 1987). Furthermore, our previous evidence suggests a
beneficial effect of propranolol on verbal problem solving
in ASD (Beversdorf et al. 2008). While it is unclear
whether noradrenergic activity is dysregulated in autism
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explore the effects of propranolol on functional connectiv-
ity between brain regions during a language task, because
of these observed cognitive effects of the drug. However,
propranolol is also utilized for lowering blood pressure and
heart rate. Since fMRI’s blood oxygenation level dependent
(BOLD) signal is heavily dependent on the hemodynamic
response, likely to be affected by changes in heart rate and
blood pressure, the effects of propranolol will be compared
to that of nadolol. Nadolol does not pass through the blood-
brain barrier while propranolol does, and therefore nadolol
has the same peripheral effects without any of the central
effects of propranolol. This will help to ensure that any
effect on functional connectivity is not an epiphenomenon
of the peripheral hemodynamic effects of propranolol. As
propranolol will block peripheral vascular receptors as well
as central receptors, any indirect central effects secondary
to peripheral effects of propranolol would be controlled for
with the propranolol vs. nadolol comparison. Therefore, we
predicted that functional connectivity would be greater after
propranolol than after nadolol, which would serve as our
primary outcome measure.
Thus, in order to address this hypothesis, we examined
the effect of these beta-adrenergic antagonists on connec-
tivity in individuals with ASD during a well characterized
word categorization task (McDermott et al. 2003), with
which performance is at ceiling in individuals with normal
intelligence, and for which phonological categorization
demonstrated a high degree of connectivity within language
areas in individuals without neurodevelopmental diagnoses
in previous studies (Tivarus et al. 2008). In general,
selective impairment in individuals with ASD occurs in
conditions which place elevated demands on information
processing (Williams et al. 2006), which manifests as a
decrease in utilization of contextual information in process-
ing of semantic information (Minshew and Goldstein 2001;
Beversdorf et al. 2000). However, impairments in phono-
logical information processing are also observed in ASD
(Schmidt et al. 2008). Phonological categorization was
utilized in this study since decreased connectivity between
distant cortical regions in ASD appears to occur across a
range of tasks (Just et al. 2004; Koshino et al. 2005), and
since high connectivity observed in unaffected individuals
with the phonological categorization task (Tivarus et al.
2008), it was expected that this task would be sensitive to
the predicted connectivity enhancing effects of the adren-
ergic agents. A phonological task was also selected since
the effects of propranolol on tasks involving searches of the
phonological network were sometimes greater than for
searches involving the semantic network in our previous
work in individuals without neurodevelopmental diagnoses
(Campbell et al. 2008) and in individuals acutely with-
drawing from cocaine (Kelley et al. 2007).
Methods
Research participants
Ten right-handed, native-English speaking adults (8 males),
aged 19–29 (mean 24.3±4.37 std dev), with a mean FSIQ
of 102.89±14.0 and an average of 12.33±0.8 years of
education, diagnosed with ASD using the ADI-R (Autism
Diagnostic Interview-Revised) (Lord et al. 1994) criteria
were recruited to participate in this study. In addition,
all subjects were diagnosed with the GADS (Gilliam
Asperger’s Disorder Scale) (Gilliam 2001) criteria for
Asperger syndrome. Two of the subjects had a diagnosis
of autism, and the other eight had a diagnosis of Asperger
Syndrome. Of the eight with Asperger Syndrome, two were
on the borderline ADI-R criteria for the Communication
Subscale in addition to being above criteria on the other
subscales. Subjects with a history of dyslexia, cardiac
disease, asthma, diabetes or thyroid disease were excluded,
as were subjects with any recent history of noradrenergic
drug use. All subjects were able to comprehend the task and
perform the task outside the scanner. Exclusion criteria also
included a history of comorbid psychiatric disorders such as
schizophrenia, major depression, bipolar disorder or major
head trauma. One subject had a history of seizures, treated
with felbamate and lamotrigine. Two had been given the
diagnosis of attention deficit disorder in the past, but were
not actively treated for this. Two had been given the
diagnosis of obsessive compulsive disorder, and one among
the two had also been diagnosed with generalized anxiety
disorder. One subject was taking sertraline and one was
taking fluoxetine, but no other psychotropics were taken by
the participants. No changes had been made in the dosages
of these medications in at least 6 months before the study.
All participants either reported normal vision, or were
provided corrective lenses in order for them to view the
fMRI stimuli. Participants were also screened to comply
with MRI safety requirements (no metallic implants or
prostheses, no metal objects in their bodies, non-
claustrophobic). Written consent was obtained from all
study participants after explaining the study and the nature
of the procedure to each participant, in accordance with the
regulations of the Institutional Review Board of The Ohio
State University.
Drug administration
All participants were required to attend one test session for
each drug, with the visits being at least 24 h apart. During
each visit, the participant was orally administered either
placebo, propranolol (40 mg), or nadolol (50 mg). The
50 mg dose of nadolol was utilized since it exhibited
identical effects on heart rate as the 40 mg dose of
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Propranolol is rapidly absorbed from the small intestine and
reaches peak plasma levels in 1–2 h after oral dose, and
nadolol, 2–4 h after the dose. The timing was also that used
in previous experiments, which revealed cognitive effects
(Beversdorf et al. 2002). Therefore, imaging was initiated
60 min after propranolol and placebo, and 120 min after
nadolol. In order to avoid learning effects, the order of drug
administration was counterbalanced, and the subjects,
imaging staff and analysis team were blinded to drug
condition. Heart rate and blood pressure were measured
before administration of the drug, and immediately before
and after the fMRI scans.
Materials
Separate groups of word-lists for phonological processing
were created for each session by modifying previously used
stimuli (McDermott et al. 2003), which have demonstrated
robust activation of phonological language areas, and
revealed a high degree of functional connectivity between
language areas in healthy controls (Tivarus et al. 2008).
Each group consisted of four word-lists, for a total of 12
lists presented to each participant over the course of the
entire experiment (Tivarus et al. 2008).
Every participant performed one version of the phono-
logical task during each visit. The task was a block design
task (Fig. 1) with 4 task blocks (24 s), each interspersed
between 5 rest blocks (30 s) for a total of 4 min and 6 s.
During each task block, a cue word was presented in
capitalized letters (3 s), followed by the corresponding
word-list (1.1 s for each word followed by a 300 ms
timeout). A ‘*’ sign was shown during the rest blocks.
Presentation and recording was done using E-Prime version
1.1 and a RF-interference free LCD monitor placed inside
the scanner room. The subject was instructed to attend to
the sound of each word in the word list, and respond
whether it rhymed with the cue word presented at the
beginning of the block, using an fMRI-compatible response
system (Lumina LP 400, Cedrus Corp., San Pedro, CA).
Imaging data acquisition and analysis
Images were collected with a 3T Philips scanner with an 8-
channel SENSE head coil. Structural T1-weighted images
were acquired using a T1 weighted 3D FFE pulse sequence
(TR=25 ms; TE=3.6 ms; 512×512 matrix; 240 mm FOV;
64 axial slices; 2.2 mm thick). BOLD contrast functional
scans were acquired using a gradient echo EPI sequence
(TR=3 s; TE=35 ms; 80×80 matrix; 230 mm FOV; 35
axial slices, 4 mm thick; α=90°). The first two images were
acquired to allow stabilization of longitudinal magnetiza-
tion and not included in further analysis. The imaging data
were analyzed using SPM8. Each BOLD series was
corrected for slice acquisition timing, motion corrected for
respiratory and other motion artifacts, normalized to the
Montreal Neurological Institute (MNI) template, and
resampled and smoothed using 5 mm Gaussian kernel to
decrease spatial noise.
Statistical analysis was performed on individual data
using the general linear model as implemented in SPM8.
Average group activation maps were generated using one
sample t-tests and between drug difference images using
two-sample t-tests as implemented in SPM8. Functional
connectivity was measured as the correlation between the
average time series of different ROI-pairs. Four ROIs known
to be activated by the phonological task (McDermott et al.
2003), including the left inferior frontal cortex (BA 44/45/
46)-LIFG, left fusiform gyrus (BA37)-LFUS, left parietal
cortex (BA7)-LPAR and left middle temporal gyrus (BA 21/
22)-LMTG, were selected a priori. Spherical (10 mm
diameter) ROIs centered within the abovementioned regions
were drawn and confirmed by a fellowship trained Behav-
ioral and Cognitive Neurologist in the Departments of
Radiology and Neurology (D.Q.B.), on the standard tem-
plate. Average time series for all voxels included in the ROI
were extracted for each participant for each drug condition
using MATLAB. Correlations of the time series between
pairs of ROIs were computed by calculating the correlation
coefficient between the time series for each ROI pair for
each subject for each drug condition. Fisher’sZ -
transformation was applied to the computed correlations for
each a priori ROI-pair to enable comparison between drug
conditions and ROI-pairs.
Results
Axial slices of average group activation maps generated
through SPM5 revealed a pattern of activity similar to
previous studies (McDermott et al. 2003; Tivarus et al.
2008) (Fig. 2), including a set of brain regions comprised of
the LIFG extending to the premotor and motor areas,
bilateral middle frontal gyrus, left posterior middle tempo-
ral gyrus, left fusiform gyrus, bilateral occipital cortex and
bilateral premotor cortex. There was no significant differ-
ence detected for any of the between-drug comparisons in
any of the a priori language-related ROIs. Errors were rare
on the task, with no subject responding with less than 88%
correct under any condition, and there were no differences
in task accuracy between drug conditions.
Repeated measures 2*6 ANOVA (drug*ROI-pair)
showed a main effect of significantly greater connectivity
[F(1,7)=7.742; P=0.027] with propranolol (mean r=0.457;
SE=0.09) as compared to nadolol (mean r=0.321; SE=0.10)
(Fig. 3). Further analysis also revealed a drug*ROI-pair
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main effect of ROI-pair [F(1,7)=7.140; P=0.068]. Analysis
of individual ROI-pairs revealed significantly [t(7)=4.263; x
p=0.004] greater functional connectivity between LIFG and
LFUS after propranolol (mean r=0.4029; SE=0.04) than
after nadolol (mean r=0.1123; SE=0.07), which withstood
Bonferroni correction. In a similar comparison between these
ROI-pairs, the main effect for the comparison between
propranolol and placebo (mean r=0.344; SE=0.11) did not
reach significance (Fig. 3), and no main effect for ROI pair
or interaction effect was found for this comparison.
There was no main effect for a difference in connectivity
between placebo and nadolol, and also no main effect for
ROI pair or interaction effect was found for this comparison.
Both heart rate (HR) and systolic blood pressure (SBP)
significantly decreased in a similar manner from baseline to
pre fMRI assessment for propranolol (paired t-tests- SBP:
p=0.017, HR: p=0.009) and nadolol (SBP p=0.006, HR:
p=0.013) and from baseline to post fMRI assessment for
propranolol (SBP: p=0.026, HR: p=0.011) and nadolol
(SBP: p=0.020, HR: p=0.0002), and no significant change
was observed with placebo for any of these conditions.
There was no significant difference in HR or SBP between
the post-drug pre fMRI assessments and post fMRI assess-
ments for placebo, propranolol, or nadolol.
Discussion
These results show that propranolol appears to increase the
functional connectivity between brain regions in ASD as
compared to nadolol. This is consistent with our hypothe-
sis, since propranolol, with central and peripheral β-
adrenergic blockade, shows increased connectivity as
compared to the condition where only peripheral β-
adrenergic receptors are blocked. The adequacy of the
nadolol as a control for the peripheral β-adrenergic effects
is supported since blood pressure and heart rate effects were
similar between nadolol and propranolol.
These results may begin to suggest an anatomic substrate
of the cognitive effects of propranolol previously reported
in ASD (Beversdorf et al. 2008). However, while this task
was chosen due to its ability to elicit a high degree of
functional connectivity in previous studies (Tivarus et al.
2008), it was not designed for concurrent assessment of
performance. Therefore, exploring the effect of the norad-
renergic system on functional connectivity in both controls
and individuals with ASD, in tasks that are known to be
modulated by the noradrenergic system and that allow for
concurrent performance monitoring is critical for better
understanding of the modulatory effect of the noradrenergic
system. Recent evidence from diffusion tensor imaging
(DTI) has suggested that the decreased functional connec-
tivity observed in autism is, at least in part, anatomically
based (Lee et al. 2007). However, our study suggests that at
least part of this decrease in connectivity can be manipu-
lated pharmacologically. Based upon the proposed effects
of the noradrenergic system on SNR (Hasselmo et al.
1997), the increase in functional connectivity between
distant brain regions with propranolol as compared to
nadolol may be an observable manifestation of the increase
in access to more remote associative inputs, which would
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Fig. 1 Task design. Task design
for one phonological task
presented in this experiment. In
the example shown, the words
brand, land and sand rhyme
with the cue word, STAND,
while the word clips does not
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Average group activation maps
during phonological processing
among individuals with autism
after administration of placebo
(a), propranolol (b), and nadolol
(c). The left portion of each
demonstrates the Maximum
Intensity Projection (MIP)
generated through SPM8
(presented in neurological
convention)
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searches of lexical/semantic/associative networks, associat-
ed with decreased noradrenergic activity (Hasselmo et al.
1997; Alexander et al. 2007). Further study examining
tasks more sensitive to pharmacological effects on perfor-
mance would be necessary to better understand the
relationship between performance and connectivity.
Whereas it was not the primary focus of this study, no
significant difference was observed between propranolol
and placebo. This may be due to the fact that the addition of
other hemodynamic factors, such as differences in blood
pressure between the drug conditions, interfered with our
ability to detect a difference between propranolol and
placebo. Specifically, propranolol decreases blood pressure
and heart rate as compared to placebo, which would likely
also impact the BOLD response in fMRI. Therefore, any
comparison between propranolol and placebo would also be
confounded by other differences in BOLD effects. By
comparing propranolol to nadolol, the blood pressure and
heart rate effects are matched between drug conditions,
minimizing any confounding effects of peripheral hemody-
namics on the BOLD response, and giving a more specific
indication of the central effects of propranolol.
The small size of this study limits our ability to draw any
firm conclusions, though, regarding the comparison be-
tween propranolol and placebo. Larger studies will be
needed to further evaluate the imaging effects of propran-
olol as compared to placebo, and the relationship between
the imaging effects and these hemodynamic factors. This
further investigation of the propranolol and placebo
comparison will be critical for better understanding of any
future clinical implications of this study. Also, our study
focused on a priori regions of interest, but future studies
will also need to examine the role of the right hemisphere
due to atypical functional lateralization of language
reported in ASD (Kleinhans et al. 2008). Furthermore, the
specific finding of increased connectivity between LIFG
and LFUS with propranolol as compared to nadolol is of
interest in light of the role of the LIFG in decision making
in language tasks (Bookheimer 2002) and the role of the
LFUS in visual word form recognition (Beversdorf et al.
1997). This suggests a specific role of propranolol in the
interaction between visual word recognition and language
decision making in phonological decision making. However,
additional study is necessary to further address this,
including the relationship between drug effects on connec-
tivity and on task performance.
Others have proposed a role of the noradrenergic system
in autism. Based on research revealing that individuals with
autism can actually have improved behaviors and commu-
nication during febrile episodes (Curran et al. 2007), it has
been proposed that fever may transiently restore adrenergic
tone in a developmentally dysregulated and hypofunction-
ing adrenergic system in autism (Mehler and Purpura
2009). Regardless of whether noradrenergic activity is
actually altered or not in ASD (Martchek et al. 2006;
Minderaa et al. 1994), the decreased flexibility of access to
phonological, semantic and associative networks in autism
(Schmidt et al. 2008; Beversdorf et al. 2000), and the
effects of propranolol on flexibility of access to such
networks (Campbell et al. 2008), would be consistent with
the imaging findings observed in this study, as well as the
cognitive effects in autism (Beversdorf et al. 2008).
Regardless of whether norepinephrine is upregulated, as
has been proposed (Lake et al. 1977; Launay et al. 1987),
or downregulated (Mehler and Purpura 2009), this points to
the relevance of understanding noradrenergic activity in
ASD, as it appears to be important. This also points to the
importance of examining both higher and lower functioning
subjects, as our findings have revealed benefits from the
beta-adrenergic antagonist propranolol in high functioning
subjects (Beversdorf et al. 2008), but many of the subjects
in the Curran et al. (2007) study revealing the beneficial
effects of fever, upon which the hypotheses of Mehler and
Purpura (2009) were based, were lower functioning
individuals with autism. Furthermore, our study predomi-
nantly examined patients with Asperger Syndrome, where
language is relatively preserved. Future studies will need to
determine whether benefits also occur in the autism patient
population, whether higher or lower functioning. Inclusion
of controls without neurodevelopmental diagnoses will also
be necessary in future studies to better understand the effect
of propranolol on functional connectivity, and whether this
effect is specific to ASD. Also, the highly selective sample
in this study limits the generalizability of any conclusions
that can be drawn from our findings.
Better converging evidence from neuropsychopharmaco-
logical studies and neuroimaging research in autism may
Fig. 3 Comparison of correlation coefficients. Mean correlation
coefficients (average over all ROI-pairs) for the phonological task
for each of the drug conditions
Brain Imaging and Behavior (2010) 4:189–197 195ultimately help guide future potential supportive treatments
for autism, if appropriate biomarkers can be identified.
Furthermore, clinical trials will also be needed in order to
better understand the clinical implications of this finding.
Also, both propranolol and nadolol are nonselective β-
adrenergic antagonists. The distinct roles of beta-1 and
beta-2 receptors in this effect will need to be determined in
future studies. Considerable effort has been undertaken to
better understand the differences between cognitive effects
of alpha and beta adrenergic receptors (for example,
Chamberlain et al. 2006), but less is known about the
differential effects of agents acting on beta-1 and beta-2
receptors. However, given recent work revealing the
apparently opposing effects of beta-1 and beta-2 receptors
on working memory, with improved working memory in
animal models with the beta-1 adrenergic antagonist,
betaxolol (Ramos et al. 2005), but improved working
memory in animal models with the beta-2 agonist,
clenbuterol (Ramos et al. 2008), better understanding of
the role of the specific beta receptors will be critical for
further investigation of the clinical implications of
noradrenergic-based treatment of ASD.
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